What is the focus of the Orange Book?

The focus of the Orange Book is primarily on FDA-approved drugs, specifically regarding therapeutic equivalence and bioequivalence. This resource, formally known as the Approved Drug Products with Therapeutic Equivalence Evaluations, serves as a critical reference for healthcare professionals, pharmacists, and manufacturers. It helps to identify which generic drugs can be considered interchangeable with brand-name drugs based on their safety and efficacy, as both must meet stringent regulatory standards.

By providing detailed information about drug formulations and their equivalent alternatives, the Orange Book plays a significant role in ensuring that patients have access to safe and effective medications at potentially lower costs. Understanding this focus aligns with the broader goals of public health and drug regulation, emphasizing the importance of drug efficacy and safety in the healthcare system. Other options, such as drug pricing, vaccine-preventable diseases, and animal drug products, do not capture the primary purpose of the Orange Book.